UNICREDIT BANK/CALL/BIOGEN IDEC/300/0.1/14.01.26 Share Price

Warrant

DE000HD28PF2

Real-time BOERSE MUENCHEN 10:41:20 26/06/2024 BST
2.14 EUR 0.00% Intraday chart for UNICREDIT BANK/CALL/BIOGEN IDEC/300/0.1/14.01.26
Current month-13.01%
1 month-5.31%
Date Price Change
26/06/24 2.14 0.00%
25/06/24 2.14 -5.31%
24/06/24 2.26 +4.15%
21/06/24 2.17 -3.13%
20/06/24 2.24 +2.75%

Real-time BOERSE MUENCHEN

Last update June 26, 2024 at 10:41 am

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying BIOGEN INC.
IssuerLogo Issuer UniCredit UniCredit
WKN HD28PF
ISINDE000HD28PF2
Date issued 29/01/2024
Strike 300 $
Maturity 14/01/2026 (568 Days)
Parity 10 : 1
Emission price 3.48
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 3.55
Lowest since issue 1.31
Delta0.4x
Omega 3.905
Premium44.71x
Gearing9.71x
Moneyness 0.7440
Difference Strike 76.81 $
Difference Strike %+25.60%
Spread 0.08
Spread %3.65%
Theoretical value 2.150
Implied Volatility 36.57 %
Total Loss Probability 75.93 %
Intrinsic value 0.000000
Present value 2.150
Break even 322.97 €
Theta-0.03x
Vega0.1x
Rho0.1x

Company Profile

Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (17,2%) ; - other (9,1%): primarily revenues from partnership agreements.
Sector
-
More about the company

Ratings for Biogen Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Biogen Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
35
Last Close Price
223.2 USD
Average target price
283.2 USD
Spread / Average Target
+26.87%
Consensus